GB00B9GTXM62
GB00B9GTXM62
Silence Therapeutics, Plc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 559.000 | 43.258.000 | 98.7% |
| Cost of Revenue | 215.000 | 11.810.000 | 98.2% |
| Gross Profit | 344.000 | 31.448.000 | 98.9% |
| 90.097.000 | 94.767.000 | 4.9% | |
| Operating Income | -89.753.000 | -63.319.000 | 41.7% |
| Pretax Income | -88.601.000 | -44.464.000 | 99.3% |
| Net Income Common Stockholders | -88.612.000 | -45.309.000 | 95.6% |
| -- | -- | -- | |
| -- | -- | -- |